BACKGROUND: Increased telomere shortening has been demonstrated in several diseases including type 2 diabetes. However, it is not known whether telomere length changes during the course of type 2 diabetes. OBJECTIVE: To determine telomere length at different stages of type 2 diabetes, including early and late stages. METHODS: A total of 93 males with type 2 diabetes and 10 years or more since original diagnosis; 96 males with less than one year of diagnosis; 98 age matched healthy males. Telomere length was estimated by means of real-time polymerase chain reaction. Fasting venous blood samples were obtained for measurement of lipid peroxidation and inflammation markers. RESULTS: We found a greater telomere shortening in group (A) with type 2 diabetes of 10 years or more since original diagnosis, compared with the control group (C) of healthy males (5.4 vs 9.6 Kb) (p = 0.04) and with group B (5.4 vs 8.7 kb) (p = 0.05). With regard to inflammatory markers TNF-α, malondialdehyde peroxidation and adiponectin we found significant differences. CONCLUSION: Telomere shortening increases with the duration of diabetes. The time of exhibition suggests in parallel that the progressive increase of inflammation and/or oxidative stress plays a direct role in telomere shortening.
BACKGROUND: Increased telomere shortening has been demonstrated in several diseases including type 2 diabetes. However, it is not known whether telomere length changes during the course of type 2 diabetes. OBJECTIVE: To determine telomere length at different stages of type 2 diabetes, including early and late stages. METHODS: A total of 93 males with type 2 diabetes and 10 years or more since original diagnosis; 96 males with less than one year of diagnosis; 98 age matched healthy males. Telomere length was estimated by means of real-time polymerase chain reaction. Fasting venous blood samples were obtained for measurement of lipid peroxidation and inflammation markers. RESULTS: We found a greater telomere shortening in group (A) with type 2 diabetes of 10 years or more since original diagnosis, compared with the control group (C) of healthy males (5.4 vs 9.6 Kb) (p = 0.04) and with group B (5.4 vs 8.7 kb) (p = 0.05). With regard to inflammatory markers TNF-α, malondialdehyde peroxidation and adiponectin we found significant differences. CONCLUSION: Telomere shortening increases with the duration of diabetes. The time of exhibition suggests in parallel that the progressive increase of inflammation and/or oxidative stress plays a direct role in telomere shortening.
Authors: Keri Horan Kalmbach; Danielle Mota Fontes Antunes; Roberta Caetano Dracxler; Taylor Warner Knier; Michelle Louise Seth-Smith; Fang Wang; Lin Liu; David Lawrence Keefe Journal: Fertil Steril Date: 2013-01 Impact factor: 7.329
Authors: Frank Yeung; Cristina M Ramírez; Pedro A Mateos-Gomez; Alexandra Pinzaru; Giovanni Ceccarini; Shaheen Kabir; Carlos Fernández-Hernando; Agnel Sfeir Journal: Cell Rep Date: 2013-06-20 Impact factor: 9.423
Authors: Cindy W Leung; Barbara A Laraia; Belinda L Needham; David H Rehkopf; Nancy E Adler; Jue Lin; Elizabeth H Blackburn; Elissa S Epel Journal: Am J Public Health Date: 2014-10-16 Impact factor: 9.308
Authors: E N Dudinskaya; O N Tkacheva; M V Shestakova; N V Brailova; I D Strazhesko; D U Akasheva; O Y Isaykina; N V Sharashkina; D A Kashtanova; S A Boytsov Journal: Endocr Connect Date: 2015-06-01 Impact factor: 3.335
Authors: Emma Killick; Malgorzata Tymrakiewicz; Clara Cieza-Borrella; Paula Smith; Deborah J Thompson; Karen A Pooley; Doug F Easton; Elizabeth Bancroft; Elizabeth Page; Daniel Leongamornlert; Zsofia Kote-Jarai; Rosalind A Eeles Journal: PLoS One Date: 2014-01-29 Impact factor: 3.240